Chemoenzymatic Synthesis of Well‐Defined α(2,8)‐ and α(2,9)‐Linked Oligosialosides

J Jelle A. Fok (Division of Chemical Biology and Drug Discovery Utrecht Institute for Pharmaceutical Sciences Utrecht University Utrecht the Netherlands) K Keshav Kishor (Complex Carbohydrate Research Center University of Georgia Athens Georgia USA) M Mehman I. Bunyatov (Chemical Biology and Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, and Bijvoet Center for Biomolecular Research) G Gerlof P. Bosman (Division of Chemical Biology and Drug Discovery Utrecht Institute for Pharmaceutical Sciences Utrecht University Utrecht the Netherlands) G Geert‐Jan Boons (Division of Chemical Biology and Drug Discovery Utrecht Institute for Pharmaceutical Sciences Utrecht University Utrecht the Netherlands)

Abstract

ABSTRACT A chemoenzymatic strategy is described as a method that can readily provide well‐defined α(2,8)‐ and α(2,9)‐linked oligosialic acids of different lengths. It employs the recombinant bacterial sialic acid polymerases, NmC‐PST and NmB‐PST, in combination with cytidine 5’‐monophosphate N ‐acetylneuraminic acid (CMP‐Neu5Ac) derivatives that have a benzoyl ester at C‐9 or thioethyl ether at the C‐5 acetamide of Neu5Ac. It results in products that lack glycosyl accepting properties and hence prevent polymerization. A rationale for the blocking behavior of the C‐5 modification is provided by molecular dynamics simulations. The benzoyl ester can be removed by mild basic hydrolysis, and the thioethyl ether by reductive desulfurization to give natural Neu5Ac than can be extended in the next cycle of enzymatic sialylation and unmasking. The resulting oligosialosides are attractive materials for the development of bacterial vaccines and as probes to investigate the roles of oligosialosides in human physiology.

Article Details

Volume / Issue Vol. 1, Issue 1
Published July 13, 2026
ISSN 1433-7851
Publisher Wiley

Journal Info

Angewandte Chemie International Edition

Wiley

ISSN: 1433-7851 Physical Sciences

Authors (5)

J

Jelle A. Fok

Division of Chemical Biology and Drug Discovery Utrecht Institute for Pharmaceutical Sciences Utrecht University Utrecht the Netherlands

K

Keshav Kishor

Complex Carbohydrate Research Center University of Georgia Athens Georgia USA

M

Mehman I. Bunyatov

Chemical Biology and Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, and Bijvoet Center for Biomolecular Research

G

Gerlof P. Bosman

Division of Chemical Biology and Drug Discovery Utrecht Institute for Pharmaceutical Sciences Utrecht University Utrecht the Netherlands

G

Geert‐Jan Boons

Division of Chemical Biology and Drug Discovery Utrecht Institute for Pharmaceutical Sciences Utrecht University Utrecht the Netherlands